AbCellera and Merck Sign Novel Therapeutic Antibody Discovery Collaboration
27 janv. 2016 16h08 HE
|
AbCellera
VANCOUVER, British Columbia, Jan. 27, 2016 (GLOBE NEWSWIRE) -- AbCellera, a biotechnology company specializing in the rapid discovery of monoclonal antibodies from natural immune cells, today...